Earnings Call · Q4 FY2024·2025-03-11

Q4 24EPS -73.11%·Rev n/aQ3 24EPS -68.29%·Rev n/aQ2 24EPS -9.09%·Rev n/aQ1 24EPS +16.67%·Rev n/a⚠ consensus missing

ZEVRA THERAPEUTICS, INC. ZVRA

Nichol Ochsner — Investor Relations or Corporate Communications

Neil McFarlane — President and CEO

Joshua Schafer — Chief Commercial Officer (CCO) or Head of Commercial

LaDuane Clifton — Chief Financial Officer (CFO)

−1.9%1d on move date−2.4% vs SPY3d+3.0%5d−1.2%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ZVRA calls or request research access.

More ZVRA calls Browse calls Request research access